Page 2 - Sachdev Sidhu News Today

Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and is currently in human trials. Neovascular age-related macular degeneration (AMD) affects more than 200 million people worldwide. In addition, millions more with type-1 or type-2 diabetes are at risk of developing diabetic macular edema (DME). Both diseases currently have no cure. The novel an...

/PRNewswire/ -- AntlerA has applied its next generation programmable ANT platform to develop therapeutics for treating retinopathies. Blood vessels that supply...

Date Time Researchers develop antibody drug that could treat diabetic retinopathy The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy – a protein to treat disease. Now, a new biologic therapy developed by U of T researchers has potential to reverse a common diabetes complication. A team led by Stéphane Angers, professor and associate dean of research at the Leslie Dan Faculty of Pharmacy, has developed a synthetic ...

Pharmacy U of T researchers develop antibody drug that could treat diabetic retinopathy A team led by U of T researcher Stéphane Angers has developed a synthetic antibody as a promising treatment for diabetic retinopathy, which causes blindness and affects about one third of diabetes patients (photo by Tetra Images via Getty Images) The life-saving diabetic medication insulin, developed at the University of Toronto 100 years ago, was the first biologic therapy – a protein to treat dis...

Date Time Medicine by Design symposium highlights importance of convergence in regenerative medicine and human health Researchers are poised to make unprecedented breakthroughs in human health thanks to advances in biomedical and computational sciences that have driven critical tools and technologies such as genetic engineering, synthetic biology, and artificial intelligence. That’s the message Dr. Victor Dzau, president of the U.S. National Academy of Medicine, delivered to Medicine by Desig...

The National Academy of Inventors Dec. 8 announced its 175-person cohort of 2020 Fellows, including several Indian Americans and South Asian Americans among the group of global inventors. Among the Fellows were Ananth Annapragada of the Baylor College of Medicine; Samuel Asirvatham of the Minnesota-based Mayo Clinic; Bir Bhanu of U.C. Riverside; Venkat Bhethanabotla of the University of South Florida; V. Chandrasekar of Colorado State University; Ramalingam Chellappa of Johns Hopkins University...